Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
10.1038/leu.2008.194 Leukemia 38 DiergaardeB.BrandR.LambJ.CheongS
Lillys active ingredient tirzepatide acts as a dual agonist , mimicking two gut hormones, GIP and GLP-1 , whereas Novos semaglutide targets only GLP-1
This is where the science of liposomal delivery becomes a game changer
Compounded tirzepatide is not FDA-approved but is manufactured under pharmacy compounding standards through licensed facilities
Serious risks include pancreatitis, gallbladder disease, kidney issues, and possible gastroparesis or bowel obstruction, plus a boxed warning for thyroid Ccell tumors based on rodent data and a contraindication in patients with personal/family history of medullary thyroid carcinoma or MEN2
Best for: People interested in a dual agonist with a different receptor profile than tirzepatide, particularly those concerned about liver fat or metabolic health
US$ 23.70
US$ 23.89
US$ 21.58
US$ 22.14
US$ 20.37
US$ 21.42
